Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Weidong Li

ResearcherPublications, citations & collaboration network

Weidong Li is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 434 works, 8,779 citations, an h-index of 48 and an i10-index of 171.

434
Works
8,779
Citations
48
h-index
171
i10-index

How has Weidong Li's publication output changed over time?

ScholarIQpublication output · 1998–2024

Output grew0% over the shown period — from 1 works in 1998 to 1 in 2024.

1
1
1
1
2
1
2
1
1
199819992005200820112015202120222024

What are the most-cited papers on Weidong Li?

ScholarIQmost cited works
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations
Shun Lü, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhixiang Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lü, Yanping Hu, Liyan Jiang, Qiming Wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wan-cheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Weng Jie, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Changan Sun, Hongying Wei, Chuan Li, Siraj M. Ali, Vincent A. Miller, Qiong Wu
Journal of Clinical Oncology. 2022290 CitationsOPEN ACCESS
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
Shun Lü, Jie Wang, Yan Yu, Xinmin Yu, Yanping Hu, Xinghao Ai, Zhiyong Ma, Xingya Li, Wu Zhuang, Yunpeng Liu, Weidong Li, Jiuwei Cui, Dong Wang, Wangjun Liao, Jianying Zhou, Zhehai Wang, Yuping Sun, Xiusong Qiu, Jie Gao, Yuanyuan Bao, Liang Liang, Mengzhao Wang
Journal of Thoracic Oncology. 2021284 CitationsOPEN ACCESS
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study
Xiaoxu Huo, Leili Gao, Lixin Guo, Wen Xu, Wenbo Wang, Xinyue Zhi, Ling Li, Yanfeng Ren, Xiuying Qi, Zhong Sun, Weidong Li, Qiuhe Ji, Xingwu Ran, Benli Su, Chuan‐Ming Hao, Juming Lu, Xiaohui Guo, Hanjing Zhuo, Danyi Zhang, Changyu Pan, Jianping Weng, Dayi Hu, Xilin Yang, Linong Ji
The Lancet Diabetes & Endocrinology. 2015242 Citations
Genome Scan for Human Obesity and Linkage to Markers in 20q13
Joseph H. Lee, Danielle R. Reed, Weidong Li, Weizhen Xu, Eun-Jeong Joo, Robin L. Kilker, Elizabeth Nanthakumar, Michael North, H. Sakul, Callum J. Bell, R. Arlen Price
S134425043. 1999239 CitationsOPEN ACCESS
A Genome-Wide Association Study on Obesity and Obesity-Related Traits
Kai Wang, Weidong Li, Hu Zhang, Zuoheng Wang, Joseph Glessner, Struan F.A. Grant, Hongyu Zhao, Håkon Håkonarson, R. Arlen Price
PLoS ONE. 2011227 CitationsOPEN ACCESS

Related on ScholarIQ

Ningbo University
Institution
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations
Paper
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
Paper
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study
Paper
Genome Scan for Human Obesity and Linkage to Markers in 20q13
Paper
A Genome-Wide Association Study on Obesity and Obesity-Related Traits
Paper
470M+ articles · free account